Glycolipid depletion in antimicrobial therapy.

Glycolipid depletion in antimicrobial therapy.

Mucosal pathogens target sites of infection through specific adherence to host glycoconjugate receptors. As a consequence, depletion of such receptors from the cell surface may be expected to inhibit attachment, impair bacterial colonization and reduce the activation of mucosal inflammation. We have...

Bibliográfalaš dieđut
Váldodahkkit:	Svensson, M, Frendeus, B, Butters, T, Platt, F, Dwek, R, Svanborg, C
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2003

Geahča maid

Glycolipid receptor depletion as an approach to specific antimicrobial therapy.
Dahkki: Svensson, M, et al.
Almmustuhtton: (2006)

Carbohydrate receptor depletion as an antimicrobial strategy for prevention of urinary tract infection.
Dahkki: Svensson, M, et al.
Almmustuhtton: (2001)

Glycolipids in cell biology and medicine - Introduction
Dahkki: Dwek, R, et al.
Almmustuhtton: (2003)

Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders.
Dahkki: Butters, T, et al.
Almmustuhtton: (2003)

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy.
Dahkki: Platt, F, et al.
Almmustuhtton: (2001)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
Dahkki: Jeyakumar, M, et al.
Almmustuhtton: (2002)

Imino sugar therapy for type 1 Gaucher disease.
Dahkki: Priestman, D, et al.
Almmustuhtton: (2000)

Contributions of Glycolipid Biosurfactants and Glycolipid-Modified Materials to Antimicrobial Strategy: A Review
Dahkki: Qin Shu, et al.
Almmustuhtton: (2021-02-01)

CD1d presentation of glycolipids.
Dahkki: Speak, A, et al.
Almmustuhtton: (2008)

Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders.
Dahkki: Butters, T
Almmustuhtton: (2007)

Therapeutic applications of imino sugars in lysosomal storage disorders.
Dahkki: Butters, T, et al.
Almmustuhtton: (2003)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
Dahkki: Butters, T, et al.
Almmustuhtton: (2003)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
Dahkki: Butters, T, et al.
Almmustuhtton: (2005)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
Dahkki: Butters, T, et al.
Almmustuhtton: (2000)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
Dahkki: Butters, T, et al.
Almmustuhtton: (2005)

Substrate reduction therapy in mouse models of the glycosphingolipidoses.
Dahkki: Platt, F, et al.
Almmustuhtton: (2003)

Introduction
Dahkki: Dwek, R, et al.
Almmustuhtton: (2003)

Storage solutions: treating lysosomal disorders of the brain.
Dahkki: Jeyakumar, M, et al.
Almmustuhtton: (2005)

Glycolipids/
Dahkki: Wiegandt, H.
Almmustuhtton: (1985)

Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.
Dahkki: Mellor, H, et al.
Almmustuhtton: (2003)

Targeting glycosylation as a therapeutic approach.
Dahkki: Dwek, R, et al.
Almmustuhtton: (2002)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
Dahkki: Andersson, U, et al.
Almmustuhtton: (2000)

Control of Alicyclobacillus acidoterrestris in Apple Juice with Natural Antimicrobial Glycolipid
Dahkki: Rory Wang, et al.
Almmustuhtton: (2025-02-01)

Substrate reduction therapy
Dahkki: Platt, F, et al.
Almmustuhtton: (2007)

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.
Dahkki: Garner, B, et al.
Almmustuhtton: (2002)

Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.
Dahkki: Andersson, U, et al.
Almmustuhtton: (2004)

The liganding of glycolipid transfer protein is controlled by glycolipid acyl structure.
Dahkki: Lucy Malinina, et al.
Almmustuhtton: (2006-11-01)

Tuning the antimicrobial activity of microbial glycolipid biosurfactants through chemical modification
Dahkki: Melike Pala, et al.
Almmustuhtton: (2024-02-01)

New developments in treating glycosphingolipid storage diseases.
Dahkki: Platt, F, et al.
Almmustuhtton: (2005)

Glycosylation: disease targets and therapy.
Dahkki: Zitzmann, N, et al.
Almmustuhtton: (2005)

High-performance cation-exchange chromatography and pulsed amperometric detection for the separation, detection, and quantitation of N-alkylated imino sugars in biological samples.
Dahkki: Mellor, H, et al.
Almmustuhtton: (2000)

Inhibition of glycogen breakdown by imino sugars in vitro and in vivo.
Dahkki: Andersson, U, et al.
Almmustuhtton: (2004)

Soluble human TLR2 ectodomain binds diacylglycerol from microbial lipopeptides and glycolipids.
Dahkki: Jiménez-Dalmaroni, M, et al.
Almmustuhtton: (2015)

Glycolipids : new research /
Dahkki: Sasaki, Daiki
Almmustuhtton: (c200)

Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
Dahkki: Norris-Cervetto, E, et al.
Almmustuhtton: (2004)

Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.
Dahkki: Jeyakumar, M, et al.
Almmustuhtton: (2001)

Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin.
Dahkki: Walden, C, et al.
Almmustuhtton: (2006)

Synergistic Treatment of Breast Cancer by Combining the Antimicrobial Peptide Piscidin with a Modified Glycolipid
Dahkki: Rebecca T. Miceli, et al.
Almmustuhtton: (2024-07-01)

Pyroelectric detection in glycolipid thin film
Dahkki: Kwong, W.L., et al.
Almmustuhtton: (2010)

Pharmacological impairment of acrosome formation and sperm head morphogenesis reveals essential role of glycosphingolipids in spermiogenesis
Dahkki: van der Spoel, A, et al.
Almmustuhtton: (2002)